<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diffuse large B cell lymphoma: Management of first relapse or primary refractory disease in transplant-eligible patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diffuse large B cell lymphoma: Management of first relapse or primary refractory disease in transplant-eligible patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Diffuse large B cell lymphoma: Management of first relapse or primary refractory disease in transplant-eligible patients</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm describes management for transplant-eligible patients with primary refractory DLBCL or first relapse. Many institutions limit transplantation to patients ≤75 years with adequate heart, kidney, and liver function and performance status. Refer to related UpToDate material for details of fitness for transplantation, diagnosis, treatment, and response assessment.</div><div class="graphic_footnotes"><p>DLBCL: diffuse large B cell lymphoma;
CAR-T cell: chimeric antigen receptor T cell;
PET: positron emission tomography;
HCT: hematopoietic cell transplantation;
CR: complete response;
PR: partial response.</p>
<p>* If CAR-T cell therapy is not available, autologous HCT is an acceptable, yet less effective option.</p>
<p>¶ Refer to related UpToDate material for descriptions of salvage chemotherapy regimens.</p>
<p>Δ Management of second or later relapse of DLBCL is addressed separately.</p>
◊ UpToDate contributors differ in managing patients with PR after salvage therapy; either approach is considered acceptable.</div><div id="graphicVersion">Graphic 142186 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
